Browse All

Current Filters

CLEAR FILTER x

TITLE

Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment

Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged =65 years with episodic or chronic migraine

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients